高通量技术筛选主动脉夹层生物标志物的研究

傅强, 邓小芳, Akindavyi Gael, 等. 高通量技术筛选主动脉夹层生物标志物的研究[J]. 临床心血管病杂志, 2021, 37(10): 952-958. doi: 10.13201/j.issn.1001-1439.2021.10.016
引用本文: 傅强, 邓小芳, Akindavyi Gael, 等. 高通量技术筛选主动脉夹层生物标志物的研究[J]. 临床心血管病杂志, 2021, 37(10): 952-958. doi: 10.13201/j.issn.1001-1439.2021.10.016
FU Qiang, DENG Xiaofang, Akindavyi Gael, et al. Biomarkers of aortic dissection screened by high-throughput technology[J]. J Clin Cardiol, 2021, 37(10): 952-958. doi: 10.13201/j.issn.1001-1439.2021.10.016
Citation: FU Qiang, DENG Xiaofang, Akindavyi Gael, et al. Biomarkers of aortic dissection screened by high-throughput technology[J]. J Clin Cardiol, 2021, 37(10): 952-958. doi: 10.13201/j.issn.1001-1439.2021.10.016

高通量技术筛选主动脉夹层生物标志物的研究

详细信息
    通讯作者: 邓婷,E-mail:dengting8763@163.com
  • 中图分类号: R543.1

Biomarkers of aortic dissection screened by high-throughput technology

More Information
  • 目的:通过iTRAQ联合Label-free法筛选主动脉夹层潜在诊断标志物。方法:入选急性主动脉夹层及对照组(急性冠状动脉综合征)血清各50例。将两组患者中各15例血清标本用于iTRAQ及Label-free分析筛选表达差异蛋白。对所有收集血清进行差异蛋白的免疫吸附测定(ELISA)验证。结果:两组血清标本使用iTRAQ方法共鉴定出84种差异表达蛋白质,Label-free方法共鉴定有或无差异蛋白20种。通过Panther软件进行生信分析与主动脉夹层发病机制9种相关蛋白作为候选生物标志物。进行ELISA验证后得出2种差异蛋白Lumican、PI16有统计学差异,且特异性和敏感性较高。结论:蛋白Lumican、PI16可能成为主动脉夹层潜在的诊断标志物。
  • 加载中
  • [1]

    Hagan PG,Nienaber CA,Isselbacher EM,et al.The international registry of acute aortic dissection(IRAD):new insights into an old disease[J].JAMA,2000,283(7):897-903.

    [2]

    Klompas M.Does this patient have an acute thoracic aortic dissection?[J].JAMA,2002,287(17):2262-2272.

    [3]

    Salmasi MY,Al-Saadi N,Hartley P,et al.The risk of misdiagnosis in acute thoracic aortic dissection:a review of current guidelines[J].Heart,2020,106(12):885-891.

    [4]

    Suzuki T,Distante A,Zizza A,et al.Preliminary experience with the smooth muscle troponin-like protein,calponin,as a novel biomarker for diagnosing acute aortic dissection[J].Eur Heart J,2008,29(11):1439-1445.

    [5]

    He Y,Ma C,Xing J,et al.Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection[J].BMC Cardiovasc Disord,2019,19(1):282.

    [6]

    König KC,Lahm H,Dreβen M,et al.Aggrecan:a new biomarker for acute type A aortic dissection[J].Sci Rep,2021,11(1):10371.

    [7]

    Wang Y,Tan X,Gao H,et al.Magnitude of soluble ST2 as a novel biomarker for acute aortic dissection[J].Circulation,2018,137(3):259-269.

    [8]

    Peng W,Peng Z,Chai X,et al.Potential biomarkers for early diagnosis of acute aortic dissection[J].Heart Lung,2015,44(3):205-208.

    [9]

    Paparella D,Malvindi PG,Scrascia G,et al.D-dimers are not always elevated in patients with acute aortic dissection[J].J Cardiovasc Med(Hagerstown),2009,10(2):212-214.

    [10]

    Wen T,Liu L,Xiong GZ.Matrix metalloproteinase levels in acute aortic dissection,acute pancreatitis and other abdominal pain[J].Emerg Med J,2009,26(10):715-718.

    [11]

    Núňez EV,Domont GB,Nogueira F.iTRAQ-based shotgun proteomics approach for relative protein quantification[J].Methods Mol Biol,2017,1546:267-274.

    [12]

    Zhang DM,Feng LX,Liu M,et al.Possible target-related proteins and signal network of bufalin in A549 cells suggested by both iTRAQ-based and label-free proteomic analysis[J].Proteomics,2016,16(6):935-945.

    [13]

    Song Y,Xie Y,Liu F,et al.Expression of matrix metalloproteinase-12 in aortic dissection[J].BMC Cardiovasc Disord,2013,13:34.

    [14]

    Harris KM,Strauss CE,Eagle KA,et al.Correlates of delayed recognition and treatment of acute type A aortic dissection:the International Registry of Acute Aortic Dissection(IRAD)[J].Circulation,2011,124(18):1911-1918.

    [15]

    van Kimmenade RR,Januzzi JL Jr.Emerging biomarkers in heart failure[J].Clin Chem,2012,58(1):127-138.

    [16]

    Nienaber CA,Eagle KA.Aortic dissection:new frontiers in diagnosis and management:Part II:therapeutic management and follow-up[J].Circulation,2003,108(6):772-778.

    [17]

    Del Porto F,di Gioia C,Tritapepe L,et al.The multitasking role of macrophages in Stanford type A acute aortic dissection[J].Cardiology,2014,127(2):123-129.

    [18]

    Shinohara T,Suzuki K,Okada M,et al.Soluble elastin fragments in serum are elevated in acute aortic dissection[J].Arterioscler Thromb Vasc Biol,2003,23(10):1839-1844.

    [19]

    Zhou X,Wang R,Zhang T,et al.Identification of lysophosphatidylcholines and sphingolipids as potential biomarkers for acute aortic dissection via serum metabolomics[J].Eur J Vasc Endovasc Surg,2019,57(3):434-441.

    [20]

    Paparella D,Malvindi PG,Scrascia G,et al.D-dimers are not always elevated in patients with acute aortic dissection[J].J Cardiovasc Med(Hagerstown),2009,10(2):212-214.

    [21]

    Vianello E,Dozio E,Rigolini R,et al.Acute phase of aortic dissection:a pilot study on CD40 L,MPO,and MMP-1,-2,9 and TIMP-1 circulating levels in elderly patients[J].Immun Ageing,2016,13:9.

    [22]

    Parker LA,Chilet-Rosell E,Hernández-Aguado I,et al.Diagnostic biomarkers:are we moving from discovery to clinical application?[J].Clin Chem,2018,64(11):1657-1667.

    [23]

    Schoenhoff FS,Fu Q,Van Eyk JE.Cardiovascular proteomics:implications for clinical applications[J].Clin Lab Med,2009,29(1):87-99.

    [24]

    Xiao Z,Xue Y,Yao C,et al.Acute aortic dissection biomarkers identified using isobaric tags for relative and absolute quantitation[J].Biomed Res Int,2016,2016:6421451.

    [25]

    Gu G,Cheng W,Yao C,et al.Quantitative proteomics analysis by isobaric tags for relative and absolute quantitation identified Lumican as a potential marker for acute aortic dissection[J].J Biomed Biotechnol,2011,2011:920763.

    [26]

    Feala JD,Abdulhameed MD,Yu C,et al.Systems biology approaches for discovering biomarkers for traumatic brain injury[J].J Neurotrauma,2013,30(13):1101-1116.

    [27]

    Singhmar P,Trinh R,Ma J,et al.The fibroblast-derived protein PI16 controls neuropathic pain[J].Proc Natl Acad Sci U S A,2020,117(10):5463-5471.

    [28]

    Hazell GG,Peachey AM,Teasdale JE,et al.PI16 is a shear stress and inflammation-regulated inhibitor of MMP2[J].Sci Rep,2016,6:39553.

    [29]

    Christensen D,Brown FE,Cree AJ,et al.Sorsby fundus dystrophy-A review of pathology and disease mechanisms[J].Exp Eye Res,2017,165:35-46.

    [30]

    Li R,Zhao L,Wu N,et al.Proteomic analysis allows for identifying targets of Yinchenwuling Powder in hyperlipidemic rats[J].J Ethnopharmacol,2016,185:60-67.

    [31]

    Jin H,Kang GY,Jeon S,et al.Identification of molecular signatures involved in radiation-induced lung fibrosis[J].J Mol Med(Berl),2019,97(1):37-47.

    [32]

    Naito Z.Role of the small leucine-rich proteoglycan(SLRP)family in pathological lesions and cancer cell growth[J].J Nippon Med Sch,2005,72(3):137-145.

    [33]

    De Simone V,Franzè E,Ronchetti G,et al.Th17-type cytokines,IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth[J].Oncogene,2015,34(27):3493-3503.

    [34]

    Meng F,Li J,Yang X,et al.Role of Smad3 signaling in the epithelial-mesenchymal transition of the lens epithelium following injury[J].Int J Mol Med,2018,42(2):851-860.

  • 加载中
计量
  • 文章访问数:  505
  • PDF下载数:  0
  • 施引文献:  0
出版历程
收稿日期:  2021-03-14
修回日期:  2021-07-24

目录